To Assess the Effectiveness of Using the Hemovigilance Guidelines in Preventing Blood Transfusion Errors and Ensuring the Safe Provision of Blood to Patients at Bamrasnaradura Infectious Diseases Institute

Abstract

     This is a study to assess the effectiveness of using Hemovigilance guidelines to prevent the transfusion of blood to the wrong blood group or individual, ensuring safety in blood transfusions at the Bamrasnaradura Infectious Diseases Institute (BIDI). The study involved collecting data on the number of adverse events and post-transfusion reactions, as well as information related to blood components and the blood bank's operational processes at the institute. The study divided into three periods times are 1) Hemovigilance guidelines¹ were first implemented in January 2014 and continued until December 2018, 2) Data collection continued when Hemovigilance guidelines were integrated into the institute's operational processes from January 2019 to December 2022 and 3) monitoring and evaluation took place from January 2023 until September 2023.
     From the data study, the results of this study for these 3 periods are as follows: Blood transfusion to the wrong person: 2, 0, 0 times, Mismatch between blood type registered in the medical records and the laboratory check: 5, 3, 1 times, Errors in the process of receiving blood and storing blood components in the blood bank: 12, 2, 0 times, Instances of incorrect blood type identification from the donor blood bag: 0, 0, 0 times, Expired blood units: 235, 83, 16 units, Laboratory check process errors: 4, 2, 0 times, Blood administration errors: 2, 1, 0 times, Giving blood to the wrong person: 0, 0, 0 times, Administering the wrong blood type: 0, 0, 0 times, Adverse reactions after blood reception and blood components: 24, 13, 7 times, Because there was inadequate control of blood temperature during transportation (blood cold chain) and repeat blood type check before blood reception not matching the blood type results, it was not performed before the hemovigilance system was used. Data from all 3 periods are: Not performed, 8, 1 times and not performed, 0, 0 times respectively
     Based on the study's findings, the Blood Bank has developed and improved its operational guidelines in collaboration with healthcare professionals to minimize adverse reactions in patients. The implementation of Hemovigilance guidelines at the BIDI has promoted the institute's role as a national-level reporting and surveillance center for blood safety. This positions the institute to provide data for analysis and recommendations for the development of safe blood transfusion and blood component practices in the country.